Alyvant uses de-identified patient-level analytics to better understand the nuances of a disease, patterns of physician prescribing, and payer reimbursement. We then turn insights into action through our fit-for-purpose commercial pharmaceutical organization. Our long-range vision is to use technology to reduce the cost of commercializing all medicines, thereby generating savings for the healthcare system at large and helping to ensure that every patient who might benefit from an approved therapy has the opportunity to speak with a physician about appropriate treatment options.